CIC bioGUNE, a member of the Basque Research & Technology Alliance (BRTA), is hosting until Thursday, 25 November, the congress of the BactiVax Project, a European training network funded by the Europ...
Read moreISGlobal and the CISM participated in several of the studies leading to the report, including one on the mid and long-term neurological impact of GBS infections among survivors
Read moreExtension of the Sartorius cell culture media business with a focus on media for gene therapeutics and vaccines
Read moreInterview with Dr. Manel Juan, head of the Immunology Service
Read moreThis Sunday, on World Microbiome Day, more than 500 experts will meet virtually to attend the International Human Microbiome Consortium Congress 2021, the world's most important congress in the field ...
Read moreAlgenex SL, a biotech company backed by Cleon Capital and Columbus Ventures delivering disruptive technologies for recombinant biologics production, has taken significant steps towards full commercial...
Read moreRibbon cutting attended by the Prime Minister of the Republic of Slovenia, Janez Janša Innovative products for the purification of advanced agents such as mRNA or adenoviruses for the manufacture of...
Read moreCrises reveal the shortcomings we must face and pose a series of challenges that we must address from an ethical standpoint. The situation we are currently experiencing with COVID-19 is a clear exa...
Read moreA single virus has been able to spread all around the world in a few months and almost paralyze the country’s economy for a whole year: SARS-CoV2. During this time, we have accumulated restrictio...
Read moreLipid nanoparticles are a vital component of the new Pfizer/BioNTech and Moderna mRNA COVID-19 vaccines, playing a key role in protecting and transporting the mRNA effectively to the right place in ce...
Read morePall Corporation expands production capacity in the United States and Europe to support industry demand
Read moreWe began 2020 refreshed and hopeful, with plans to publish unique perspectives and insights to inspire new ideas in the months to come—but COVID-19 changed everything. As the world adapted and recon...
Read more